Company intelligence / Profile preview
Oisín Biotechnologies
Seattle, Washington, United States
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Preclinical data published showing significant increases in muscle mass (+50%) and strength (+100%) in animal models using follistatin gene therapy delivered by PLV. Demonstrated clearance of senescent cells leading to lifespan extension (>20% increase in median lifespan in aged mice). The PLV platform has passed Phase II human trials as a COVID vaccine delivery system, supporting safety[3][5][9].
- Therapeutic areas
- OtherNephrology
- Modalities
- Genetic medicines / gene therapyDNA and RNA therapeutics delivered via proprietary nonviral delivery systemSenolytic therapies targeting senescent cellsTherapies targeting muscle growth and adipocyte elimination
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Licensing relationship with Entos Pharmaceuticals for Fusogenix PLV platformAbbVie Ventures is a lead investor and board participant following Series A financing[3][7].
Beyond the preview
Go deeper on Oisín Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oisín Biotechnologies.